TipRanks
CSL (CMXHF)
OTHER OTC:CMXHF
US Market
CMXHF
CSL
RESEARCH TOOLSreports

CSL (CMXHF) Stock Forecast & Price Target

89 Followers
See the Price Targets and Ratings of:

CMXHF Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
6 Buy
5 Hold
0 Sell
Based on 11 analysts giving stock ratings to
CSL
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CMXHF Stock 12 Month Forecast

Average Price Target

$126.86
▲(1.79% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for CSL in the last 3 months. The average price target is $126.86 with a high forecast of $149.77 and a low forecast of $104.49. The average price target represents a 1.79% change from the last price of $124.63.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"64":"$64","107":"$107","150":"$150","85.5":"$85.5","128.5":"$128.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":149.769,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$149.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":126.85782599999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$126.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":104.49,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$104.49</span>\n  </div></div>","useHTML":true}}],"tickPositions":[64,85.5,107,128.5,150],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.405,125.433,127.461,129.489,131.517,133.54500000000002,135.573,137.601,139.62900000000002,141.657,143.685,145.71300000000002,147.741,{"y":149.769,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.405,123.670602,123.936204,124.201806,124.46740799999999,124.73301,124.998612,125.264214,125.529816,125.795418,126.06101999999998,126.32662199999999,126.59222399999999,{"y":126.85782599999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.405,121.95,120.495,119.03999999999999,117.585,116.13,114.675,113.22,111.765,110.31,108.85499999999999,107.39999999999999,105.945,{"y":104.49,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":128.685,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.36,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.644,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.527,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.169,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.567,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.251,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.805,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.956,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.505,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.731,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":120.937,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.405,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$149.77Average Price Target$126.86Lowest Price Target$104.49
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CMXHF
David Bailey
Morgan Stanley
Morgan Stanley
$126.78
Buy
1.73%
Upside
Reiterated
10/12/26
Morgan Stanley Reaffirms Their Buy Rating on CSL (CMXHF)
Macquarie Analyst forecast on CMXHF
Christine Trinh
Macquarie
Macquarie
$121.21
Hold
-2.75%
Downside
Reiterated
10/09/26
Macquarie Keeps Their Hold Rating on CSL (CMXHF)
Citi Analyst forecast on CMXHF
Laura Sutcliffe
Citi
Citi
$111.46→$125.39
Hold
0.61%
Upside
Reiterated
10/08/26
Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Demant (Other OTC: WILLF)
Jefferies Analyst forecast on CMXHF
David Stanton
Jefferies
Jefferies
$102.05→$112.5
Hold
-9.73%
Downside
Reiterated
10/06/26
Analysts Conflicted on These Healthcare Names: vTv Therapeutics (NASDAQ: VTVT) and CSL (Other OTC: CMXHF)
RBC Capital Analyst forecast on CMXHF
Craig Wong-Pan
RBC Capital
RBC Capital
$148.38→$149.77
Buy
20.17%
Upside
Reiterated
10/06/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Ord Minnett Analyst forecast on CMXHF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$125.39
Buy
0.61%
Upside
Reiterated
10/04/26
CSL (CMXHF) Gets a Buy from Ord Minnett
Canaccord Genuity Analyst forecast on CMXHF
Shane Storey
Canaccord Genuity
Canaccord Genuity
$128.87
Hold
3.40%
Upside
Reiterated
10/01/26
Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Newron Pharmaceuticals SpA (Other OTC: NWPHF)
UBS Analyst forecast on CMXHF
David Low
UBS
UBS
$126.08
Buy
1.17%
Upside
Reiterated
09/02/26
UBS Sticks to Its Buy Rating for CSL (CMXHF)
Morgans Analyst forecast on CMXHF
Derek Jellinek
Morgans
Morgans
$130.76
Buy
4.92%
Upside
Reiterated
09/01/26
Analysts' Top Healthcare Picks: Oneview Healthcare Chess Depository Interests repr 1 (ONVVF), CSL (CMXHF)
Jarden Analyst forecast on CMXHF
Steven Wheen
Jarden
Jarden
$144.2
Buy
15.70%
Upside
Upgraded
08/19/26
Positive Report for CSL (CMXHF) from Jarden
Bell Potter Analyst forecast on CMXHF
Thomas Wakim
Bell Potter
Bell Potter
$83.59→$104.49
Hold
-16.16%
Downside
Reiterated
08/19/26
Bell Potter Keeps Their Hold Rating on CSL (CMXHF)
Goldman Sachs Analyst forecast on CMXHF
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
$216.64→$147.75
Buy
18.55%
Upside
Reiterated
10/29/25
Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)
CLSA Analyst forecast on CMXHF
Andrew Paine
CLSA
CLSA
$219.43→$191.57
Buy
53.71%
Upside
Reiterated
10/13/25
CLSA Keeps Their Buy Rating on CSL (CMXHF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CMXHF
David Bailey
Morgan Stanley
Morgan Stanley
$126.78
Buy
1.73%
Upside
Reiterated
10/12/26
Morgan Stanley Reaffirms Their Buy Rating on CSL (CMXHF)
Macquarie Analyst forecast on CMXHF
Christine Trinh
Macquarie
Macquarie
$121.21
Hold
-2.75%
Downside
Reiterated
10/09/26
Macquarie Keeps Their Hold Rating on CSL (CMXHF)
Citi Analyst forecast on CMXHF
Laura Sutcliffe
Citi
Citi
$111.46→$125.39
Hold
0.61%
Upside
Reiterated
10/08/26
Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Demant (Other OTC: WILLF)
Jefferies Analyst forecast on CMXHF
David Stanton
Jefferies
Jefferies
$102.05→$112.5
Hold
-9.73%
Downside
Reiterated
10/06/26
Analysts Conflicted on These Healthcare Names: vTv Therapeutics (NASDAQ: VTVT) and CSL (Other OTC: CMXHF)
RBC Capital Analyst forecast on CMXHF
Craig Wong-Pan
RBC Capital
RBC Capital
$148.38→$149.77
Buy
20.17%
Upside
Reiterated
10/06/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Ord Minnett Analyst forecast on CMXHF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$125.39
Buy
0.61%
Upside
Reiterated
10/04/26
CSL (CMXHF) Gets a Buy from Ord Minnett
Canaccord Genuity Analyst forecast on CMXHF
Shane Storey
Canaccord Genuity
Canaccord Genuity
$128.87
Hold
3.40%
Upside
Reiterated
10/01/26
Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Newron Pharmaceuticals SpA (Other OTC: NWPHF)
UBS Analyst forecast on CMXHF
David Low
UBS
UBS
$126.08
Buy
1.17%
Upside
Reiterated
09/02/26
UBS Sticks to Its Buy Rating for CSL (CMXHF)
Morgans Analyst forecast on CMXHF
Derek Jellinek
Morgans
Morgans
$130.76
Buy
4.92%
Upside
Reiterated
09/01/26
Analysts' Top Healthcare Picks: Oneview Healthcare Chess Depository Interests repr 1 (ONVVF), CSL (CMXHF)
Jarden Analyst forecast on CMXHF
Steven Wheen
Jarden
Jarden
$144.2
Buy
15.70%
Upside
Upgraded
08/19/26
Positive Report for CSL (CMXHF) from Jarden
Bell Potter Analyst forecast on CMXHF
Thomas Wakim
Bell Potter
Bell Potter
$83.59→$104.49
Hold
-16.16%
Downside
Reiterated
08/19/26
Bell Potter Keeps Their Hold Rating on CSL (CMXHF)
Goldman Sachs Analyst forecast on CMXHF
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
$216.64→$147.75
Buy
18.55%
Upside
Reiterated
10/29/25
Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)
CLSA Analyst forecast on CMXHF
Andrew Paine
CLSA
CLSA
$219.43→$191.57
Buy
53.71%
Upside
Reiterated
10/13/25
CLSA Keeps Their Buy Rating on CSL (CMXHF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
ASNDAscendis Pharma
QNCXQuince Therapeutics
EHCEncompass Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSL

3 Months
David BaileyMorgan Stanley
Success Rate
11/24 ratings generated profit
46%
Average Return
+1.19%
Copying David Bailey's trades and holding each position for 3 Months would result in 45.83% of your transactions generating a profit, with an average return of +1.19% per trade.
1 Year
David BaileyMorgan Stanley
Success Rate
11/24 ratings generated profit
46%
Average Return
-1.73%
Copying David Bailey's trades and holding each position for 1 Year would result in 45.83% of your transactions generating a profit, with an average return of -1.73% per trade.
2 Years
David BaileyMorgan Stanley
Success Rate
9/24 ratings generated profit
38%
Average Return
-2.83%
Copying David Bailey's trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of -2.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CMXHF Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
11
8
2
0
0
Buy
1
5
8
13
12
Hold
19
23
21
20
16
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
36
31
33
28
In the current month, CMXHF has received 12 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. CMXHF average Analyst price target in the past 3 months is 126.86.
Each month's total comprises the sum of three months' worth of ratings.

CMXHF Financial Forecast

CMXHF Earnings Forecast

Next quarter’s earnings estimate for CMXHF is $3.98 with a range of $3.62 to $4.28. The previous quarter’s EPS was $2.26. CMXHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CMXHF has Performed in-line its overall industry.
Next quarter’s earnings estimate for CMXHF is $3.98 with a range of $3.62 to $4.28. The previous quarter’s EPS was $2.26. CMXHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CMXHF has Performed in-line its overall industry.

CMXHF Sales Forecast

Next quarter’s sales forecast for CMXHF is $8.44B with a range of $8.36B to $8.52B. The previous quarter’s sales results were $7.35B. CMXHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CMXHF has Performed in-line its overall industry.
Next quarter’s sales forecast for CMXHF is $8.44B with a range of $8.36B to $8.52B. The previous quarter’s sales results were $7.35B. CMXHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CMXHF has Performed in-line its overall industry.

CMXHF Stock Forecast FAQ

What is CMXHF’s average 12-month price target, according to analysts?
Based on analyst ratings, CSL’s 12-month average price target is 126.86.
    What is CMXHF’s upside potential, based on the analysts’ average price target?
    CSL has 1.79% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CMXHF a Buy, Sell or Hold?
          CSL has a consensus rating of Moderate Buy which is based on 6 buy ratings, 5 hold ratings and 0 sell ratings.
            What is CSL’s price target?
            The average price target for CSL is 126.86. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $149.77 ,the lowest forecast is $104.49. The average price target represents 1.79% Increase from the current price of $124.63.
              What do analysts say about CSL?
              CSL’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of CMXHF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.